Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma

Background: DLBCL represent a heterogeneous group of aggressive diseases. High grade B-cell lymphomas (HGBCL) were recently individualized from DLBCL as a discrete diagnostic entity due to their worse prognosis. Currently, although most patients are successfully treated with RCHOP regimens, 1/3 will...

Descripción completa

Detalles Bibliográficos
Autores principales: Petronilho, Sara, Sequeira, José Pedro, Paulino, Sofia, Lopes, Paula, Lisboa, Susana, Chacim, Sérgio, Lobo, João, Teixeira, Manuel, Jerónimo, Carmen, Henrique, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703891/
https://www.ncbi.nlm.nih.gov/pubmed/34945856
http://dx.doi.org/10.3390/jpm11121384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703891/
https://www.ncbi.nlm.nih.gov/pubmed/34945856
http://dx.doi.org/10.3390/jpm11121384

Ejemplares similares